The NDLVC phenotype. arrhythmic prognosis and differences with dilated cardiomyopathy.

12 April 2026 (08:00 - 15:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Nikias Milaras

Ippokrateio General Hospital of Athens, Athens (Greece)

196 More presentations in this session

Presentation thumbnail

Comparison of ECG findings between young patients with cryptogenic ischemic stroke and stroke-free control subjects

Doctor J. Uutela (Jyvaskyla, FI)

Presentation thumbnail

A wearable SCG-based approach for early, low-cost screening of valvular heart disease

Doctor V. Pergola (Naples, IT)

Presentation thumbnail

Intraoperative assessment of cardiac parasympathetic tone using short-term HRV metrics before and after atropine administration: a pilot study

Doctor B. Hrymniak (Wroclaw, PL)

Presentation thumbnail

Arrhythmia phenotypes in hair-loss therapies: insights from minoxidil and finasteride reports in eudravigilance

Doctor Y. Shhab (Bucharest, RO)

Presentation thumbnail

Arrhythmias and device therapy in HFpEF: Insights from a real-world hospital cohort

Ms A. Bondoc (Timisoara, RO)

Abstract Slides Video

Access the full session

Session thumbnail

Poster session (3): mechanisms and management of arrhythmias

The Event

Event poster

EHRA 2026

12 April - 14 April 2026

You may be interested in

Congress Presentation

Temporal variability of ECG risk markers and clinical outcomes in non-dilated left ventricular cardiomyopathy

Congress Presentation

Comparative outcomes of ischemic and non-ischemic dilated cardiomyopathy in ICD recipients: a 30-Year retrospective analysis

Congress Presentation

Advanced heart failure in patients with dilated cardiomyopathy and high-risk arrhythmic genotypes

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources